Complexa lands $62 mln Series C

Pennsylvania-based Complexa Inc, a clinical stage biopharmaceutical company, has closed $62 million in Series C funding. New Enterprise Associates and Pfizer Venture Investments LLC led the round with participation from other investors that included Edmond de Rothschild Investment Partners and HBM Healthcare Investments.

Source: Press Release